Disposition of 7500 shares by Berger Harold D. of CryoCell International at 2.4 subject to Rule 16b-3

Read at macroaxis.com

Published over two months ago View all stories for CryoCell International | CryoCell International Hype Analysis

Disposition of 7500 stock option at 2.4 of CryoCell International by Berger Harold D. on 27th of May 2025. This event was filed by CryoCell International with SEC on 2022-07-07. Statement of changes in beneficial ownership - SEC Form 4

We analyze CryoCell International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CryoCell International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CryoCell International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CryoCell International stock to make a market-neutral strategy. Peer analysis of CryoCell International could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics with similar companies.

Check out CryoCell International Hype Analysis, CryoCell International Correlation and CryoCell International Performance. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.